Pharma & Lifesciences

Compress Launches. Reach Patients Faster. Prove Equity.

Speed. Precision. Outcomes.

Two years, not fifteen. The first 18 months determine 50% of lifetime sales. Adelo compresses time-to-value through hyperlocal precision—reaching HCPs and patients where they concentrate, with evidence that speaks to their region.

Schedule a Demo
Explore Geo Mapping

What It Delivers

  • Identify hidden patient populations.
    Map by place-of-birth, disease vectors, and SDOH barriers—revealing where patients concentrate and what stands in their way.
  • Reach HCPs with local evidence.
    Neighborhood-level KOL networks and compliance-ready advisory boards drive adoption fast.
  • Prove outcomes and equity faster.
    Studio-quality webinars, advisory discussions, patient forums—geographically targeted, locally relevant.
  • Build real-world evidence from the ground up.
    Measure adoption by geography. Demonstrate health equity impact. Get payer evidence before competitors.

How It Works

From planning to impact, in three steps.

  • 1 Map and Target
    Geomapping identifies high-opportunity neighborhoods. SDOH + activity data reveals patient concentration and barriers.
  • 2 Engage Locally
    Host webinars in priority communities. Convene advisory boards. Deploy on-demand clinical resources.
  • 3 Measure and Scale
    Track outcomes by geography. Replicate in look-alike neighborhoods. Speed to national reach.
USE CASES

How adelo Delivers

USES CASE ONE
Rare Disease & Unmet Need

Identify hidden populations. Prioritize medical affairs where disease burden is greatest.

USES CASE TWO
Therapy Launches

Reach HCPs and patients in high-opportunity neighborhoods simultaneously. Compress launch timelines.

USES CASE THREE
Rx-to-OTC Transitions

Identify communities with highest self-care engagement. Build consumer adoption evidence. Support regulatory filings with real-world data.

USES CASE FOUR
Health Equity & Access

Map underserved communities. Demonstrate payer-ready health equity outcomes.

SEE IT IN ACTION

Global Rare Disease Launch

Precision Patient Mapping Across 15 Countries

A leading biopharmaceutical company mapped patient populations down to the neighborhood across 15 markets using place-of-birth SDOH data and migration patterns. 

Commercial teams deployed market-specific playbooks equipping field teams with local KOL strategies. Result: unprecedented HCP activation and market-leading revenue performance.

Explore Geomapping
SEE IT IN ACTION

Health Equity Through Precision

Refugee and Migrant Population

A major pharma company identified refugee and migrant populations across Europe as care gaps.

By mapping SDOH and health activity patterns, they uncovered specific neighborhoods where vulnerable populations concentrated but traditional outreach missed them. Result: successful interventions and data supporting payer reimbursement decisions.

Explore Geomapping

Ready to Compress Your Launch Timeline?

Experience Adelo’s precision targeting for pharma and lifesciences.

Get Started
Why us?

Stop guessing where patients are.
Know—and engage with precision.

Trusted by leading health, wellness and pharmaceutical brands
Get a Demo